Alyssa Vito

727 total citations
18 papers, 555 citations indexed

About

Alyssa Vito is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alyssa Vito has authored 18 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alyssa Vito's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Alyssa Vito is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Alyssa Vito collaborates with scholars based in Canada, United States and Australia. Alyssa Vito's co-authors include Nader El-Sayes, Karen Mossman, John F. Valliant, Nancy Janzen, Yonghong Wan, Alfredo Capretta, Samuel T. Workenhe, Afaf R. Genady, Omar Salem and Jon Zubieta and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Alyssa Vito

18 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alyssa Vito Canada	11	210	204	146	139	103	18	555
Lynsey A. Huxham Canada	13	300 1.4×	276 1.4×	195 1.3×	147 1.1×	100 1.0×	15	806
Abhijit Aithal United States	12	372 1.8×	428 2.1×	218 1.5×	163 1.2×	115 1.1×	23	809
Danfeng Luo China	17	160 0.8×	328 1.6×	106 0.7×	95 0.7×	53 0.5×	31	659
Francisco J. Cimas Spain	13	199 0.9×	330 1.6×	78 0.5×	93 0.7×	61 0.6×	29	596
Yael Ben‐Nun Israel	13	196 0.9×	248 1.2×	135 0.9×	192 1.4×	27 0.3×	17	658
Neha Papneja Canada	2	370 1.8×	237 1.2×	271 1.9×	86 0.6×	52 0.5×	4	723
Giulia Pellizzari United Kingdom	8	160 0.8×	253 1.2×	143 1.0×	38 0.3×	72 0.7×	12	570
Lingyi Sun China	12	228 1.1×	258 1.3×	84 0.6×	64 0.5×	172 1.7×	34	659
Tal Flieswasser Belgium	9	232 1.1×	171 0.8×	165 1.1×	74 0.5×	84 0.8×	10	508
Hiroyuki Kashiwagi Japan	13	338 1.6×	348 1.7×	122 0.8×	97 0.7×	30 0.3×	42	818

Countries citing papers authored by Alyssa Vito

Since Specialization

Citations

This map shows the geographic impact of Alyssa Vito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alyssa Vito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alyssa Vito more than expected).

Fields of papers citing papers by Alyssa Vito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alyssa Vito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alyssa Vito. The network helps show where Alyssa Vito may publish in the future.

Co-authorship network of co-authors of Alyssa Vito

This figure shows the co-authorship network connecting the top 25 collaborators of Alyssa Vito. A scholar is included among the top collaborators of Alyssa Vito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alyssa Vito. Alyssa Vito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Hansen, Aaron R., David A. Pattison, Amanda J. Walker, et al.. (2025). Phase Ib/IIa dose escalation and expansion study of [ ²¹² Pb]Pb-ADVC001 in metastatic castration-resistant prostate cancer: TheraPb–phase I/II study.. Journal of Clinical Oncology. 43(5_suppl). 1 indexed citations

Zhong, Toni, Glenn G. Fletcher, Muriel Brackstone, et al.. (2025). Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer: A Systematic Review. Current Oncology. 32(4). 231–231. 1 indexed citations

Zhong, Toni, Glenn G. Fletcher, Muriel Brackstone, et al.. (2025). Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline. Current Oncology. 32(6). 357–357. 1 indexed citations

Vito, Alyssa, Nader El-Sayes, Susan E. Collins, et al.. (2023). Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells. Cancers. 15(4). 1295–1295. 10 indexed citations

El-Sayes, Nader, Scott R. Walsh, Alyssa Vito, et al.. (2022). IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity. Molecular Therapy — Oncolytics. 25. 16–30. 13 indexed citations

El-Sayes, Nader, Alyssa Vito, Omar Salem, et al.. (2022). A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner. International Journal of Molecular Sciences. 23(3). 1754–1754. 11 indexed citations

Vito, Alyssa. (2021). Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer. MDPI (MDPI AG). 17 indexed citations

Vito, Alyssa, Omar Salem, Nader El-Sayes, et al.. (2021). Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells. Communications Biology. 4(1). 859–859. 16 indexed citations

El-Sayes, Nader, Alyssa Vito, & Karen Mossman. (2021). Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy. Cancers. 13(4). 806–806. 118 indexed citations

10.

Vito, Alyssa, et al.. (2021). Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer. International Journal of Molecular Sciences. 22(9). 4843–4843. 1 indexed citations

11.

Vito, Alyssa, Nader El-Sayes, Omar Salem, Yonghong Wan, & Karen Mossman. (2021). Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer. Cancers. 13(21). 5590–5590. 3 indexed citations

12.

Workenhe, Samuel T., Andrew Nguyen, David Bakhshinyan, et al.. (2020). De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors. Communications Biology. 3(1). 645–645. 41 indexed citations

13.

Vito, Alyssa, Nader El-Sayes, & Karen Mossman. (2020). Hypoxia-Driven Immune Escape in the Tumor Microenvironment. Cells. 9(4). 992–992. 189 indexed citations

14.

Vito, Alyssa, et al.. (2016). A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives. PLoS ONE. 11(12). e0167425–e0167425. 19 indexed citations

15.

Vito, Alyssa, Nancy Janzen, Max Nanao, et al.. (2016). Preparation of an ¹⁸F‐Labeled Hydrocyanine Dye as a Multimodal Probe for Reactive Oxygen Species. Chemistry - A European Journal. 23(2). 254–258. 44 indexed citations

16.

Vito, Alyssa, Afaf R. Genady, Nancy Janzen, et al.. (2016). A Bone-Seeking trans-Cyclooctene for Pretargeting and Bioorthogonal Chemistry: A Proof of Concept Study Using ^99mTc- and ¹⁷⁷Lu-Labeled Tetrazines. Journal of Medicinal Chemistry. 59(20). 9381–9389. 35 indexed citations

17.

Vito, Alyssa, Aimen Zlitni, Denis Beckford-Vera, et al.. (2015). ¹²⁵I-Tetrazines and Inverse-Electron-Demand Diels–Alder Chemistry: A Convenient Radioiodination Strategy for Biomolecule Labeling, Screening, and Biodistribution Studies. Bioconjugate Chemistry. 27(1). 207–216. 31 indexed citations

18.

Valliant, John F., et al.. (2014). Synthesis and evaluation of single amino acid chelate (SAAC) tetrazine derivatives for bioorthogonal conjugation with Re/99mTc. Nuclear Medicine and Biology. 41(7). 614–615. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact